Exaltare adds Kahn as MD to team


Exaltare Capital Partners has hired Benjamin Kahn as a managing director. Previously, Kahn worked at H.I.G. Growth Partners where he was a principal.

PRESS RELEASE

BOSTON–(BUSINESS WIRE)–Exaltare Capital Partners, LLC (“Exaltare”) is pleased to announce the addition of Benjamin Kahn as a Managing Director. Ben joined from H.I.G. Growth Partners where he served as a Principal in the Boston office and had worked for nine years.

“We are excited to have a professional with Ben’s background and level of private equity experience join our team. Ben has a proven track record investing in and managing portfolio companies across Exaltare’s four key industry verticals. With the recent closing of our initial institutional private equity fund, Ben will help lead our investment effort as we look to further build the portfolio,” commented Omar Simmons, founder and Managing Partner of Exaltare.

Mr. Kahn has over eighteen years of private equity experience. Prior to joining Exaltare, he served as a Principal at H.I.G. Growth Partners, the growth capital investment affiliate of H.I.G. Capital. Previously in his career he held positions at Glencoe Capital and Madison Dearborn Partners. He began his career in the investment banking division of Bear Stearns.

About Exaltare Capital Partners, LLC
Exaltare is a private equity firm focused on acquiring lower middle market businesses. Based in Boston, MA, Exaltare’s principals have significant private equity and operational experience that enables the firm to be a value-added partner to its portfolio companies. Exaltare is currently investing out of Exaltare Capital Partners Fund I, L.P., a $90 million pool of capital raised in October 2017. For more information, please refer to the Exaltare website at www.exaltarecapital.com.

Take your pick!

  • Buyouts delivers exclusive news and analysis about private equity deals, fundraising, top-quartile managers and more. Get your FREE trial or subscribe now.
  • VC Journal provides exclusive news and analysis about venture capital deals, fundraising, top-quartile investors and more. Get your FREE trial or subscribe now.